High frequency of mutations related to impaired CYP2C9 metabolism in a Caucasian population

European Journal of Clinical Pharmacology

Volumn 57, Issue 1, 2001, Pages 47-49

  Garcia Martin E ^a   Martinez C ^a   Ladero, J M ^a   Gamito, F J G ^b   Agundez J A G ^b  

^a UNIVERSITY OF EXTREMADURA   (Spain)

^b Service of Ga uroemeroloev   (Spain)

Author keywords

Allele frequency; CYP2C9; Genotype

Indexed keywords

CYTOCHROME P450 2C9;

ALLELISM; ARTICLE; CAUCASIAN; ENZYME METABOLISM; ETHNIC DIFFERENCE; GENE AMPLIFICATION; GENE MUTATION; GENOTYPE; HUMAN; NORMAL HUMAN; PRIORITY JOURNAL;

ADULT; ARYL HYDROCARBON HYDROXYLASES; CHI-SQUARE DISTRIBUTION; CONFIDENCE INTERVALS; CYTOCHROME P-450 ENZYME SYSTEM; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; GENOTYPE; HUMANS; MIDDLE AGED; MUTATION; STEROID 16-ALPHA-HYDROXYLASE; STEROID HYDROXYLASES;

EID: 0035040710     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280100264     Document Type: Article

References (17)

1. Biochemistry and molecular biology of the human CYP2C subfamily
2. Relationship between CYP2C9 and CYP2C19 genotypes and tolbutamide methyl hydroxylation and S-mephenytoin 4′-hydroxylation activities in livers of Japanese and Caucasian populations
3. Cytochrome P4502C9: An enzyme of major importance in drug metabolism
4. The role of the CYP2C9-Leu359 allelic variant in the tolbutamide polymorphism
5. The R144C change in the CYP2C9*2 allele alters interaction of the cytochrome P450 with the NADPH: Cytochrome P450 oxidoreductase
6. Allelic variants of the human cytochrome P450 2C9: Baculovirus-mediated expression, purification, structural characterization, substrate stereoselectivity, and prochiral selectivity of the wild-type and I359L mutant forms
7. Prevalence of CYP2D6 gene duplication and its repercussion on the oxidative phenotype in a white population
8. Polymorphic human cytochrome P450 enzymes. Polymorphic human cytochrome P450 enzymes: An opportunity for individualized drug treatment
9. Validation of methods for CYP2C9 genotyping: Frequencies of mutant alleles in a Swedish population
10. Confidence intervals
11. Genetic analysis of the human cytochrome P450 CYP2C9 locus
12. Frequency of cytochrome P450 CYP2C9 variants in a Turkish population and functional relevance for phenytoin
13. CYP2C9 mutant alleles in a rural U.S. Caucasian population
14. Allelic and functional variability of cytochrome P4502C9
15. Genetic polymorphism of the CYP2C subfamily and its effect on the pharmacokinetics of phenytoin in Japanese patients with epilepsy
16. Genetic association betweensensitivity to warfarin and expression of CYP2C9*3
17. Association of polymorphisms in the cytochrome P450 CYP2C9 withwarfarin dose requirement and risk of bleeding complications